title: Antitumor activity of polyoxomolybdate, [NH3Pri]6[Mo7O24].3H2O, against, human gastric cancer model.
abstract: Polyoxometalates are negatively charged inorganic compounds which contain metal ions such as tungsten, molybdenum, vanadium etc. and which make clusters with the surrounding oxygen atoms. [NH3Pri]6[Mo7O24].3H2O (PM-8) was found to be a significant antitumor polyoxomolybdates. It had already been reported that the PM-8 suppressed the growth of Co-4 human colon cancer, MX-1 human breast cancer and OAT human lung cancer xenografted in nude mice. However, the mechanism of the antitumor activity has not been clarified. In this study, the antitumor activity of one of the metal oxide clusters (polyoxometalates), hexabis(isopropylammonium) heptamolybdate trihydrate, [NH3Pri]6[Mo7O24].3H2O (PM-8) were shown in an MTS assay. DNA ladder formation and detection of apoptotic bodies in nuclei were revealed that antitumor activity of PM-8 in MKN45 cells was due to apoptosis. It is concluded that the observation of significant tumor growth suppression of PM-8 in MKN45-bearing mice results from the induction of apoptosis. PM-8 shows promise as a novel anti-cancer agent.
authors.affiliation: Chemical Research Laboratory, Tokyo Institute of Technology, R1-21, 4259 Nagatsuta, Midori-ku, Yokohama 226-8503, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Mitsui
authors.forename: A
authors.initials: A
authors.lastname: Ogata
authors.forename: H
authors.initials: H
authors.lastname: Yanagie
authors.forename: H
authors.initials: H
authors.lastname: Kasano
authors.forename: T
authors.initials: T
authors.lastname: Hisa
authors.forename: T
authors.initials: T
authors.lastname: Yamase
authors.forename: M
authors.initials: M
authors.lastname: Eriguchi
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D045744:Cell Line, Tumor; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D008982:Molybdenum / Q000627:therapeutic use*; D010087:Oxides / Q000627:therapeutic use*; D013047:Specific Pathogen-Free Organisms; D013274:Stomach Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D010087:Oxides; C081971:PM 8; D008982:Molybdenum